Home
gpo.gov
govinfo.gov

e-CFR Navigation Aids

Browse

Simple Search

Advanced Search

 — Boolean

 — Proximity

 

Search History

Search Tips

Corrections

Latest Updates

User Info

FAQs

Agency List

Incorporation By Reference

eCFR logo

Related Resources

Electronic Code of Federal Regulations

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We have made big changes to make the eCFR easier to use. Be sure to leave feedback using the Help button on the bottom right of each page!

e-CFR data is current as of September 17, 2020

Title 38Chapter IPart 4Subpart B → §4.79


Title 38: Pensions, Bonuses, and Veterans' Relief
PART 4—SCHEDULE FOR RATING DISABILITIES
Subpart B—Disability Ratings


§4.79   Schedule of ratings—eye.

Diseases of the Eye

    Rating
General Rating Formula for Diseases of the Eye:
Evaluate on the basis of either visual impairment due to the particular condition or on incapacitating episodes, whichever results in a higher evaluation
With documented incapacitating episodes requiring 7 or more treatment visits for an eye condition during the past 12 months60
With documented incapacitating episodes requiring at least 5 but less than 7 treatment visits for an eye condition during the past 12 months40
With documented incapacitating episodes requiring at least 3 but less than 5 treatment visits for an eye condition during the past 12 months20
With documented incapacitating episodes requiring at least 1 but less than 3 treatment visits for an eye condition during the past 12 months10
Note (1): For the purposes of evaluation under 38 CFR 4.79, an incapacitating episode is an eye condition severe enough to require a clinic visit to a provider specifically for treatment purposes
Note (2): Examples of treatment may include but are not limited to: Systemic immunosuppressants or biologic agents; intravitreal or periocular injections; laser treatments; or other surgical interventions
Note (3): For the purposes of evaluating visual impairment due to the particular condition, refer to 38 CFR 4.75-4.78 and to §4.79, diagnostic codes 6061-6091
6000   Choroidopathy, including uveitis, iritis, cyclitis, or choroiditis.
6001   Keratopathy.
6002   Scleritis.
6006   Retinopathy or maculopathy not otherwise specified
6007   Intraocular hemorrhage.
6008   Detachment of retina.
6009   Unhealed eye injury.
Note: This code includes orbital trauma, as well as penetrating or non-penetrating eye injury
6010   Tuberculosis of eye:
Active100
Inactive: Evaluate under §4.88c or §4.89 of this part, whichever is appropriate
6011   Retinal scars, atrophy, or irregularities:
Localized scars, atrophy, or irregularities of the retina, unilateral or bilateral, that are centrally located and that result in an irregular, duplicated, enlarged, or diminished image10
Alternatively, evaluate based on the General Rating Formula for Diseases of the Eye, if this would result in a higher evaluation
6012   Angle-closure glaucoma
Evaluate under the General Rating Formula for Diseases of the Eye. Minimum evaluation if continuous medication is required10
6013   Open-angle glaucoma
Evaluate under the General Rating Formula for Diseases of the Eye. Minimum evaluation if continuous medication is required10
6014   Malignant neoplasms of the eye, orbit, and adnexa (excluding skin):
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation100
Note: Continue the 100 percent rating beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating will be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination will be subject to the provisions of §3.105(e) of this chapter. If there has been no local recurrence or metastasis, evaluate based on residuals
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that do not require therapy comparable to that for systemic malignancies:
Separately evaluate visual and nonvisual impairment, e.g., disfigurement (diagnostic code 7800), and combine the evaluations
6015   Benign neoplasms of the eye, orbit, and adnexa (excluding skin):
Separately evaluate visual and nonvisual impairment, e.g., disfigurement (diagnostic code 7800), and combine the evaluations
6016   Nystagmus, central10
6017   Trachomatous conjunctivitis:
Active: Evaluate under the General Rating Formula for Diseases of the Eye, minimum rating30
Inactive: Evaluate based on residuals, such as visual impairment and disfigurement (diagnostic code 7800)
6018   Chronic conjunctivitis (nontrachomatous):
Active: Evaluate under the General Rating Formula for Diseases of the Eye, minimum rating10
Inactive: Evaluate based on residuals, such as visual impairment and disfigurement (diagnostic code 7800)
6019   Ptosis, unilateral or bilateral:
Evaluate based on visual impairment or, in the absence of visual impairment, on disfigurement (diagnostic code 7800).
6020   Ectropion:
Bilateral20
Unilateral10
6021   Entropion:
Bilateral20
Unilateral10
6022   Lagophthalmos:
Bilateral20
Unilateral10
6023   Loss of eyebrows, complete, unilateral or bilateral10
6024   Loss of eyelashes, complete, unilateral or bilateral10
6025   Disorders of the lacrimal apparatus (epiphora, dacryocystitis, etc.):
Bilateral20
Unilateral10
6026   Optic neuropathy
6027   Cataract:
Preoperative: Evaluate under the General Rating Formula for Diseases of the Eye
Postoperative: If a replacement lens is present (pseudophakia), evaluate under the General Rating Formula for Diseases of the Eye. If there is no replacement lens, evaluate based on aphakia (diagnostic code 6029)
6029   Aphakia or dislocation of crystalline lens:
Evaluate based on visual impairment, and elevate the resulting level of visual impairment one step.
Minimum (unilateral or bilateral)30
6030   Paralysis of accommodation (due to neuropathy of the Oculomotor Nerve (cranial nerve III)).20
6032   Loss of eyelids, partial or complete:
Separately evaluate both visual impairment due to eyelid loss and nonvisual impairment, e.g., disfigurement (diagnostic code 7800), and combine the evaluations.
6034   Pterygium:
Evaluate under the General Rating Formula for Diseases of the Eye, disfigurement (diagnostic code 7800), conjunctivitis (diagnostic code 6018), etc., depending on the particular findings, and combine in accordance with §4.25
6035   Keratoconus
6036   Status post corneal transplant:
Evaluate under the General Rating Formula for Diseases of the Eye. Minimum, if there is pain, photophobia, and glare sensitivity10
6037   Pinguecula:
Evaluate based on disfigurement (diagnostic code 7800).
6040   Diabetic retinopathy
6042   Retinal dystrophy (including retinitis pigmentosa, wet or dry macular degeneration, early-onset macular degeneration, rod and/or cone dystrophy)
6046   Post-chiasmal disorders
Impairment of Central Visual Acuity
6061   Anatomical loss of both eyes1100
6062   No more than light perception in both eyes1100
6063   Anatomical loss of one eye:1
In the other eye 5/200 (1.5/60)100
In the other eye 10/200 (3/60)90
In the other eye 15/200 (4.5/60)80
In the other eye 20/200 (6/60)70
In the other eye 20/100 (6/30)60
In the other eye 20/70 (6/21)60
In the other eye 20/50 (6/15)50
In the other eye 20/40 (6/12)40
6064   No more than light perception in one eye:1
In the other eye 5/200 (1.5/60)100
In the other eye 10/200 (3/60)90
In the other eye 15/200 (4.5/60)80
In the other eye 20/200 (6/60)70
In the other eye 20/100 (6/30)60
In the other eye 20/70 (6/21)50
In the other eye 20/50 (6/15)40
In the other eye 20/40 (6/12)30
6065   Vision in one eye 5/200 (1.5/60):
In the other eye 5/200 (1.5/60)1100
In the other eye 10/200 (3/60)90
In the other eye 15/200 (4.5/60)80
In the other eye 20/200 (6/60)70
In the other eye 20/100 (6/30)60
In the other eye 20/70 (6/21)50
In the other eye 20/50 (6/15)40
In the other eye 20/40 (6/12)30
6066   Visual acuity in one eye 10/200 (3/60) or better:
Vision in one eye 10/200 (3/60):
In the other eye 10/200 (3/60)90
In the other eye 15/200 (4.5/60)80
In the other eye 20/200 (6/60)70
In the other eye 20/100 (6/30)60
In the other eye 20/70 (6/21)50
In the other eye 20/50 (6/15)40
In the other eye 20/40 (6/12)30
Vision in one eye 15/200 (4.5/60):
In the other eye 15/200 (4.5/60)80
In the other eye 20/200 (6/60)70
In the other eye 20/100 (6/30)60
In the other eye 20/70 (6/21)40
In the other eye 20/50 (6/15)30
In the other eye 20/40 (6/12)20
Vision in one eye 20/200 (6/60):
In the other eye 20/200 (6/60)70
In the other eye 20/100 (6/30)60
In the other eye 20/70 (6/21)40
In the other eye 20/50 (6/15)30
In the other eye 20/40 (6/12)20
Vision in one eye 20/100 (6/30):
In the other eye 20/100 (6/30)50
In the other eye 20/70 (6/21)30
In the other eye 20/50 (6/15)20
In the other eye 20/40 (6/12)10
Vision in one eye 20/70 (6/21):
In the other eye 20/70 (6/21)30
In the other eye 20/50 (6/15)20
In the other eye 20/40 (6/12)10
Vision in one eye 20/50 (6/15):
In the other eye 20/50 (6/15)10
In the other eye 20/40 (6/12)10
Vision in one eye 20/40 (6/12):
In the other eye 20/40 (6/12)0

1Review for entitlement to special monthly compensation under 38 CFR 3.350.

Ratings for Impairment of Visual Fields

   Rating
6080   Visual field defects:
Homonymous hemianopsia30
Loss of temporal half of visual field:
Bilateral30
Unilateral10
Or evaluate each affected eye as 20/70 (6/21)
Loss of nasal half of visual field:
Bilateral10
Unilateral10
Or evaluate each affected eye as 20/50 (6/15)
Loss of inferior half of visual field:
Bilateral30
Unilateral10
Or evaluate each affected eye as 20/70 (6/21)
Loss of superior half of visual field:
Bilateral10
Unilateral10
Or evaluate each affected eye as 20/50 (6/15)
Concentric contraction of visual field:
With remaining field of 5 degrees:1
Bilateral100
Unilateral30
Or evaluate each affected eye as 5/200 (1.5/60)
With remaining field of 6 to 15 degrees:
Bilateral70
Unilateral20
Or evaluate each affected eye as 20/200 (6/60)
With remaining field of 16 to 30 degrees:
Bilateral50
Unilateral10
Or evaluate each affected eye as 20/100 (6/30)
With remaining field of 31 to 45 degrees:
Bilateral30
Unilateral10
Or evaluate each affected eye as 20/70 (6/21)
With remaining field of 46 to 60 degrees:
Bilateral10
Unilateral10
Or evaluate each affected eye as 20/50 (6/15)
6081   Scotoma, unilateral:
Minimum, with scotoma affecting at least one-quarter of the visual field (quadrantanopsia) or with centrally located scotoma of any size10
Alternatively, evaluate based on visual impairment due to scotoma, if that would result in a higher evaluation

1Review for entitlement to special monthly compensation under 38 CFR 3.350.

Ratings for Impairment of Muscle Function

Degree of diplopiaEquivalent
visual acuity
6090   Diplopia (double vision):
(a) Central 20 degrees5/200 (1.5/60)
(b) 21 degrees to 30 degrees
(1) Down15/200 (4.5/60)
(2) Lateral20/100 (6/30)
(3) Up20/70 (6/21)
(c) 31 degrees to 40 degrees
(1) Down20/200 (6/60)
(2) Lateral20/70 (6/21)
(3) Up20/40 (6/12)
Note: In accordance with 38 CFR 4.31, diplopia that is occasional or that is correctable with spectacles is evaluated at 0 percent.
6091   Symblepharon:
Evaluate under the General Rating Formula for Diseases of the Eye, lagophthalmos (diagnostic code 6022), disfigurement (diagnostic code 7800), etc., depending on the particular findings, and combine in accordance with §4.25

(Authority: 38 U.S.C. 1155)

[73 FR 66550, Nov. 10, 2008, as amended at 83 FR 15321, Apr. 10, 2018]

Need assistance?